Afuco™ Anti-Human ZNRF3 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-ZNRF3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The ZNRF3 antibodies can be used to treat diseases with low Wnt signaling, such as short bowel syndrome, osteoporosis, diabetes, neurodegenerative diseases, and mucositis.
Supplier Creative Biolabs
Product # AFC-648CL
Pricing Inquiry
Host Human
Target ZNRF3
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Feedback